LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC. (LABT)

Healthcare · Pharmaceuticals · Price $2.24
Updated: Aug 23, 2026

LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC. (LABT) does not report cost of revenue as a separate line in its SEC filings, so gross profit cannot be calculated. This is common for IFRS filers, banks, and insurers — it reflects a reporting format, not a problem with the business. Zyberno excludes this page from search indexing rather than publish a $0 figure.

Gross Profit (TTM)
N/A
Trailing 12 Months
Growth Rate
N/A
Log-Linear Regression (0Q)
Gross Margin
N/A
Pricing Power
Revenue
N/A
Top Line Sales
Operating Income
$-15.2M
After OpEx

🧮 LABT Gross Profit Breakdown

Gross Profit = Revenue - Cost of Revenue
Revenue (Total Sales) N/A
Less: Cost of Revenue (COGS) $2.0M
Equals: Gross Profit N/A

Understanding Gross Profit

Gross Profit is Revenue minus Cost of Revenue (also called Cost of Goods Sold or COGS). It measures how much a company earns from selling its products before subtracting operating expenses. For LABT, the trailing twelve month gross profit is N/A.

Why Gross Profit Matters

Gross margin (Gross Profit / Revenue) is one of the most important indicators of pricing power and competitive advantage. Companies with high and stable gross margins typically have differentiated products, strong brands, or unique capabilities.

LABT's gross profit growth rate of N/A (based on log-linear regression of 0 quarters) indicates relatively flat or slightly declining gross profit.

Gross Margin: The Key Metric

LABT's gross margin of N/A shows what percentage of each sales dollar remains after paying direct production costs.

Gross Profit vs Other Profitability Metrics

Operating Income: $-15.2M →

Gross Profit minus operating expenses (SG&A, R&D). Shows profitability after all operating costs but before interest and taxes.

Net Income: $-15.1M →

The bottom line after all expenses including interest and taxes. The final measure of accounting profit.

Free Cash Flow: $0 →

Actual cash generated after capital expenditures. Can differ significantly from gross profit due to working capital and capex.

Revenue: N/A →

The top line that gross profit is derived from. Gross margin shows what percentage becomes gross profit.

Summary: LABT Gross Profit Trend

LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC. (LABT) does not report cost of revenue as a separate line in its SEC filings, so gross profit cannot be calculated. This is common for IFRS filers, banks, and insurers — it reflects a reporting format, not a problem with the business. Zyberno excludes this page from search indexing rather than publish a $0 figure. For complete financial analysis, view the full LABT stock report on Zyberno.

Frequently Asked Questions

What is LABT's current gross profit?

LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.'s trailing twelve month (TTM) gross profit is N/A, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring.

Is LABT's gross profit growing?

LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC. (LABT) does not report cost of revenue as a separate line in its SEC filings, so gross profit cannot be calculated. This is common for IFRS filers, banks, and insurers — it reflects a reporting format, not a problem with the business. Zyberno excludes this page from search indexing rather than publish a $0 figure.

What is LABT's gross margin?

LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC. (LABT) does not report cost of revenue as a separate line in its SEC filings, so gross profit cannot be calculated. This is common for IFRS filers, banks, and insurers — it reflects a reporting format, not a problem with the business. Zyberno excludes this page from search indexing rather than publish a $0 figure.

What is the difference between gross profit and net income?

Gross profit is Revenue minus Cost of Revenue only. Net income also subtracts operating expenses, interest, and taxes. LABT's gross profit is N/A versus net income of $-15.1M.

📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
🛡️
Margin of Safety
Valuation Gap
🎯
Expected Return
Projected Annual
Click any metric for full methodology and detailed analysis

📊 Full LABT Stock Report

See LABT's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

💵 LABT Free Cash Flow

Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.

💰 LABT Owner Earnings

Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.

📈 LABT Earnings Per Share

Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.

🎯 LABT Earnings Surprise (SUE)

See whether LABT is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

📊 LABT Revenue

Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.

💰 LABT Net Income

Analyze the bottom-line profit, P/E ratio, and net profit margin trends.

🔶 LABT Operating Income

Analyze EBIT, operating margin, and core business profitability before interest and taxes.

💜 LABT Gross Profit

Analyze gross margin, pricing power, and profitability before operating expenses.

View Full LABT Report Find More Quality Stocks
Scroll to Top